Massachusetts Financial Services CO Abbott Laboratories Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Abbott Laboratories stock. As of the latest transaction made, Massachusetts Financial Services CO holds 13,319,347 shares of ABT stock, worth $1.52 Billion. This represents 0.47% of its overall portfolio holdings.

Number of Shares
13,319,347
Previous 10,607,761 25.56%
Holding current value
$1.52 Billion
Previous $1.1 Billion 37.77%
% of portfolio
0.47%
Previous 0.35%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$100.07 - $118.13 $271 Million - $320 Million
2,711,586 Added 25.56%
13,319,347 $1.52 Billion
Q2 2024

Aug 09, 2024
SELL
$100.73 - $112.44 $22.2 Million - $24.7 Million
-220,068 Reduced 2.03%
10,607,761 $1.1 Billion
Q1 2024

May 14, 2024
SELL
$109.52 - $120.96 $134 Million - $148 Million
-1,225,199 Reduced 10.17%
10,827,829 $1.23 Billion
Q4 2023

Feb 08, 2024
SELL
$90.19 - $110.4 $139 Million - $170 Million
-1,543,960 Reduced 11.36%
12,053,028 $1.33 Billion
Q3 2023

Nov 08, 2023
SELL
$95.53 - $114.62 $435 Million - $522 Million
-4,551,738 Reduced 25.08%
13,596,988 $1.32 Billion
Q2 2023

Aug 09, 2023
SELL
$100.78 - $112.29 $303 Million - $337 Million
-3,002,767 Reduced 14.2%
18,148,726 $1.98 Billion
Q1 2023

May 10, 2023
SELL
$96.86 - $114.01 $356 Million - $419 Million
-3,676,831 Reduced 14.81%
21,151,493 $2.14 Billion
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $28.2 Million - $33.1 Million
296,516 Added 1.21%
24,828,324 $2.73 Billion
Q3 2022

Nov 09, 2022
SELL
$96.76 - $112.03 $89.4 Million - $103 Million
-923,795 Reduced 3.63%
24,531,808 $2.37 Billion
Q2 2022

Aug 09, 2022
SELL
$102.07 - $123.37 $43.3 Million - $52.4 Million
-424,495 Reduced 1.64%
25,455,603 $2.77 Billion
Q1 2022

May 11, 2022
SELL
$114.02 - $139.04 $93.3 Million - $114 Million
-818,021 Reduced 3.06%
25,880,098 $3.06 Billion
Q4 2021

Feb 10, 2022
BUY
$115.53 - $141.46 $9.58 Million - $11.7 Million
82,926 Added 0.31%
26,698,119 $3.76 Billion
Q3 2021

Nov 10, 2021
SELL
$116.66 - $129.06 $8.95 Million - $9.9 Million
-76,714 Reduced 0.29%
26,615,193 $3.14 Billion
Q2 2021

Aug 13, 2021
BUY
$105.79 - $124.53 $1.99 Million - $2.35 Million
18,836 Added 0.07%
26,691,907 $3.09 Billion
Q1 2021

May 13, 2021
SELL
$108.84 - $128.23 $46.1 Million - $54.3 Million
-423,537 Reduced 1.56%
26,673,071 $3.2 Billion
Q4 2020

Feb 12, 2021
BUY
$105.0 - $114.42 $144 Million - $157 Million
1,374,952 Added 5.35%
27,096,608 $2.97 Billion
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $111 Million - $135 Million
1,216,669 Added 4.96%
25,721,656 $2.8 Billion
Q2 2020

Nov 20, 2020
BUY
$76.57 - $98.0 $3.76 Million - $4.81 Million
49,132 Added 0.2%
24,504,987 $2.24 Billion
Q2 2020

Aug 11, 2020
SELL
$76.57 - $98.0 $228 Million - $291 Million
-2,974,056 Reduced 10.84%
24,455,855 $2.24 Billion
Q1 2020

Nov 20, 2020
BUY
$62.82 - $91.86 $3.54 Million - $5.18 Million
56,411 Added 0.21%
27,429,911 $2.16 Billion
Q1 2020

May 14, 2020
SELL
$62.82 - $91.86 $230 Million - $337 Million
-3,666,922 Reduced 11.81%
27,373,500 $2.16 Billion
Q4 2019

Nov 25, 2020
BUY
$78.51 - $87.4 $4.76 Million - $5.3 Million
60,618 Added 0.2%
31,040,422 $2.7 Billion
Q4 2019

Feb 13, 2020
SELL
$78.51 - $87.4 $76.3 Million - $84.9 Million
-971,647 Reduced 3.04%
30,979,804 $2.69 Billion
Q3 2019

Nov 20, 2020
BUY
$81.84 - $88.74 $5.11 Million - $5.55 Million
62,487 Added 0.2%
31,951,451 $2.67 Billion
Q3 2019

Nov 05, 2019
SELL
$81.84 - $88.74 $23.4 Million - $25.4 Million
-285,849 Reduced 0.89%
31,888,964 $2.67 Billion
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $42.4 Million - $49.4 Million
-581,500 Reduced 1.78%
32,174,813 $2.71 Billion
Q1 2019

May 13, 2019
SELL
$66.22 - $80.06 $58.5 Million - $70.8 Million
-884,148 Reduced 2.63%
32,756,313 $2.62 Billion
Q4 2018

Feb 08, 2019
SELL
$65.56 - $74.27 $325 Million - $368 Million
-4,956,088 Reduced 12.84%
33,640,461 $2.43 Billion
Q3 2018

Oct 25, 2018
SELL
$60.81 - $73.36 $33 Million - $39.8 Million
-541,950 Reduced 1.38%
38,596,549 $2.83 Billion
Q2 2018

Jul 30, 2018
SELL
$57.57 - $63.54 $38.9 Million - $42.9 Million
-674,986 Reduced 1.7%
39,138,499 $2.39 Billion
Q1 2018

May 04, 2018
SELL
$56.27 - $63.62 $189 Million - $214 Million
-3,359,589 Reduced 7.78%
39,813,485 $2.39 Billion
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $322 Million - $345 Million
-5,999,218 Reduced 12.2%
43,173,074 $2.46 Billion
Q3 2017

Nov 14, 2017
SELL
$48.06 - $53.64 $241 Million - $269 Million
-5,021,130 Reduced 9.27%
49,172,292 $2.62 Billion
Q2 2017

Aug 14, 2017
BUY
N/A
54,193,422
54,193,422 $2.63 Billion

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email